Segments Covered in the Global Acute Myeloid Leukemia Treatment Market Report:
The global acute myeloid leukemia treatment market is segmented based on treatment type, distribution channel, region as follows:
- Treatment Type (Revenue, USD Million; 2022–2030)
- Chemotherapy
- Targeted Therapy
- Others
- Distribution Channel (Revenue, USD Million; 2022–2030)
- Hospital Pharmacies
- Specialty Pharmacies
- Online Pharmacies
- Region (Revenue, USD Million; 2022–2030)
- North America
- U.S.
- Canada
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Rest of Europe
- Asia Pacific
- China
- Japan
- South Korea
- India
- ASEAN
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Rest of LATAM
- Middle East & Africa
- Saudi Arabia
- UAE
- Rest of MEA
- North America
Frequently Asked Questions
Current market size: US$ 1222.2 Mn
Factors contributing to growth: Rising prevalence of AML and increasing adoption of novel therapies
Key factors hampering growth: High cost of treatment and limited access to care
Leading component segment: Chemotherapy drugs
Major players: Pfizer, Novartis, AbbVie, Celgene, Amgen
CAGR and market size by 2030: 11.9% and US$ 2,685.1 Mn by 2030